All News Items

When Yvette Crawley of Apex was diagnosed in 2021 with a rare retinal disorder that would gradually rob her of her vision, there was no available treatment. Now there is: thanks to a Duke ophthalmological surgery team, Crawley recently became the first patient to receive a new cell-based gene therapy treatment from an academic medical center.

School of Medicine researchers will be prominently featured at the seventh annual Invented at Duke event presented by the Office of Translation & Commercialization on Nov 11. Registration is free and open to all for this year's event at Penn Pavilion.

For most of rural America, access to clinical research addressing rural health is extremely limited. As a leader of a program designed to develop future researchers through hands-on experience and mentorship, Danny Benjamin, MD, PhD, MPH, is working to address this shortage.

Duke research suggests that extremely fast bursts of radiation may have the potential to target cancer cells and boost immune response while sparing healthy tissue.

Through interdisciplinary research, community engagement, and data-driven strategies, the new Climate and Health Research Initiative (CHeRI) will unite efforts across Duke and advance efforts in the Duke University School of Medicine, Duke Global Health Institute, Nicholas School of the Environment, and the Nicholas Institute for Energy, Environment & Sustainability.

Duke research reveals that a decades-old breast cancer vaccine may have unlocked a powerful immune memory response, now supercharged by a new antibody.

Duke Pathology has implemented a new platform in the My Duke Health patient portal that distills complex medical terminology into easy-to-understand plain language explanations and diagrams.

From breast cancer to rare pediatric diseases, federally funded Duke biomedical research has helped Duke staff and faculty and their families.

Doctors are taking a closer look at how obesity affects breast cancer and whether popular weight loss drugs might fit into future breast cancer prevention and treatment strategies.

Researchers at Duke University School of Medicine have identified two enzymes that can produce a key ingredient in antibiotics, antivirals, and cancer drugs without the use of toxic chemicals.